Pharvaris Presents Data Highlighting the Potential for Deucrictibant to Prevent and Treat Bradykinin-Mediated Angioedema Attacks at the EAACI Congress
ZUG, Switzerland, June 16, 2025 ( GLOBE NEWSWIRE ) -- Pharvaris ( Nasdaq: PHVS ) , a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema ( HAE ) ...
Sarepta Therapeutics Stock Plummets Over 40% On Second Fatal Case Linked To Its Gene Therapy - Sarepta Therapeutics ( NASDAQ:SRPT ) , Roche Holding ( OTC:RHHBY )
Sarepta shares fell ~40% in premarket after reporting a second patient death linked to Elevidys. Sarepta halted Elevidys shipments for non-ambulatory patients and paused dosing in the ENVISION trial. 9 Out of the Last 10 Summers this "Power Pattern" Delivered Winners - Get The Details Now.
Ocular Therapeutix™ to Participate in Clinical Trials at the Summit ( CTS ) 2025 - Ocular Therapeutix ( NASDAQ:OCUL )
BEDFORD, Mass., June 16, 2025 ( GLOBE NEWSWIRE ) -- Ocular Therapeutix, Inc. OCUL "Ocular" ) ) , a fully-integrated biopharmaceutical company committed to redefining the retina experience, today announced participation at Clinical Trials at the Summit 2025, taking place on June 21, 2025, in Las ...
Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator ( PoNS® ) Device - Helius Medical Tech ( NASDAQ:HSDT )
- CignaHealth becomes fifth major payer to authorize claim for PoNS Device at out-of-network adjusted negotiated list price of $19,161- -This follows another recent authorization by Anthem Multiplan for PoNS Device at out-of-network negotiated price of $19,160-
Ocular Therapeutix™ to Participate in Clinical Trials at the Summit ( CTS ) 2025
BEDFORD, Mass., June 16, 2025 ( GLOBE NEWSWIRE ) -- Ocular Therapeutix, Inc. ( NASDAQ: OCUL, "Ocular" ) , a fully-integrated biopharmaceutical company committed to redefining the retina experience, today announced participation at Clinical Trials at the Summit 2025, taking place on June 21, ...
Mirasol Signs MOU for the Sale of the Virginia Silver Project and Landholdings in Argentina for US$8 Million Plus 2% NSR Royalty - Mirasol Resources ( OTC:MRZLF )
Ampere Metals to acquire Virginia Project for a total consideration of US$ 8.0 million: US$5 million for the sale of the mineral rights and US$3 million for the sale of the landholdings over 5 years of scheduled payments
Chicago Atlantic Real Estate Finance Declares Common Stock Dividend of $0.47 for the Second Quarter of 2025 - Chicago Atlantic Real ( NASDAQ:REFI )
CHICAGO, June 16, 2025 ( GLOBE NEWSWIRE ) -- Chicago Atlantic Real Estate Finance, Inc. REFI, a commercial mortgage real estate investment trust, announced that its board of directors has declared a regular quarterly cash dividend of $0.47 per share for the second quarter of 2025.
ORIGENCE ENHANCES ARC OS PLATFORM UNDERWRITING WITH EXPERIAN'S POWERCURVE DECISIONING INTEGRATION
Irvine, California, June 16, 2025 ( GLOBE NEWSWIRE ) -- Origence, a leader in credit union lending technology, announced the integration of Experian's PowerCurve® decisioning suite into the Origence arc OS loan and account origination platform.
USA Rare Earth and Moog Sign Memorandum of Understanding for Delivery of U.S.-Made Neo Magnets for Data Center Cooling Solutions
USAR to Qualify its Magnets for use in Moog's CoreMotion™ Liquid Coolant Distribution Pumps USAR to Qualify its Magnets for use in Moog's CoreMotion™ Liquid Coolant Distribution Pumps ...
